- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05906186
Study Intestinal Complaints During Chemotherapy.
June 7, 2023 updated by: Spaarne Gasthuis
Study intestinal complaints during chemotherapy.
A prospective study into intestinal complaints in patients undergoing chemotherapy treatment.
A pre and post implementation design is used to establish if eating two kiwi fruits per day can prevent constipation.
Study Overview
Detailed Description
The Medical Research Involving Human Subjects Act (WMO) does not apply to this research.
Nonetheless it will be conducted according to the principals of Good Clinical Practice (GCP), privacy legislation (AVG) and Medical Treatment Agreement Act (WGBO).
The consumption of eating two kiwi's a day can be seen as a slight variation on standard advice with regards to a healthy diet.
Maintaining a diary may take some time from the participant but at the same time is of use during follow up visits where side effects, including the occurrence of constipation are discussed.
The The study is approved by the Advisory Committee on Local Feasibility (ACLU) of the Spaarne Gasthuis.
Study Type
Observational
Enrollment (Estimated)
80
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nienke de Beer, MSc
- Phone Number: +31232240000
- Email: Ndebeer@spaarnegasthuis.nl
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
For this study adult patients undergoing their first neo adjuvant or adjuvant chemotherapy are included.
Description
Inclusion Criteria:
- First chemotherapy/cytostatics treatment
- Neo-adjuvant or adjuvant treatment
- Performance status World Health Organization (WHO) 0-1
- Age 18+
- Written informed consent
- Command of the Dutch language
Exclusion Criteria:
- Kiwi allergy
- Patients using standard laxatives prior to the first chemotherapy/cytostatic treatment.
- Patients with a history of bowel resection
- Patients with stoma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Pre-test
Standard care: all patients who are starting their first (neo adjuvant or adjuvant) treatment with chemotherapy visit the nurse practitioner.
Site effects like constipation will be discussed and the prescription of laxatives is standard care.
Participants will keep a stool pattern diary during two months using the Bristol Stool Scale (BSS).
During follow up the occurrence of side effect, such as nausea, diarrhea and constipation is assessed.
|
|
Post-test
After the first four months (pre-test phase) of the study, nurse practitioners are asked, as lifestyle advice, to eat two kiwis per day instead of two pieces of fruit.
A similar group of patients undergoing their first (neo-adjuvant or adjuvant) chemotherapy treatment are approached with a request to participate in the study.
Participants keep a diary of defecation patterns for two months using the Bristol Stool Scale (BSS).
During follow-up, the occurrence of side effects such as nausea, diarrhea and constipation will be assessed.
|
eating two kiwifruits a day
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
1. How common are constipation symptoms in patients undergoing chemotherapy treatment?
Time Frame: 1 year
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
2. Does the use of laxatives decrease when consuming two kiwi's a day?
Time Frame: 1 year
|
1 year
|
3. Which interventions against constipation do patients experience as the most comfortable?
Time Frame: 1 year
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2023
Primary Completion (Estimated)
May 1, 2024
Study Completion (Estimated)
May 30, 2024
Study Registration Dates
First Submitted
June 7, 2023
First Submitted That Met QC Criteria
June 7, 2023
First Posted (Actual)
June 15, 2023
Study Record Updates
Last Update Posted (Actual)
June 15, 2023
Last Update Submitted That Met QC Criteria
June 7, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2023.0026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional Constipation (FC) | Chronic Idiopathic Constipation (CIC)United States, United Kingdom, Bulgaria, Netherlands
-
usMIMA S.L.University of York; County Durham and Darlington NHS Foundation TrustNot yet recruitingConstipation | Constipation-predominant Irritable Bowel Syndrome | Constipation - Functional | Constipation Chronic Idiopathic | Constipation; Neurogenic
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
-
ProgenaBiomeRecruitingConstipation | Constipation - Functional | Constipation Chronic Idiopathic | Constipation (Excl Faecal Impaction)United States
-
Chulalongkorn UniversityNot yet recruitingFunctional ConstipationThailand
-
Min-Tze LIONGDeyang People's HospitalRecruiting
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional ConstipationUnited States, Bulgaria, United Kingdom, Croatia, Germany, Hungary
Clinical Trials on kiwifruit
-
University of ArkansasCompletedProtein | MetabolismUnited States
-
Umm Al-Qura UniversityCompletedFatigue | Body Weight | Sleep DisturbanceSaudi Arabia
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Completed
-
University of NottinghamZespri International LimitedCompletedConstipation | Diet ModificationUnited Kingdom
-
University of PisaCompleted
-
University of MichiganCompletedKiwifruit, Prunes, & Fiber for Abdominal and Bowel Symptoms in US Patients With Chronic ConstipationChronic ConstipationUnited States
-
Zespri International LimitedCompletedIrritable Bowel SyndromeItaly